{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:25:38Z","timestamp":1791851138800,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.semarthrit.2010.11.002","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T04:43:25Z","timestamp":1296621805000},"page":"256-264","source":"Crossref","is-referenced-by-count":262,"title":["Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases"],"prefix":"10.1016","volume":"41","author":[{"given":"Roberto","family":"Perez-Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Perez-de-Lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candido","family":"Diaz-Lagares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Pego-Reigosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Retamozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Bove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Brito-Zeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"Camus","year":"2004","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.11.002_bib3","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials","volume":"43","author":"Charles","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.11.002_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1191\/0961203302lu236cr","article-title":"Drug-induced lupus following treatment with infliximab in rheumatoid arthritis","volume":"11","author":"Favalli","year":"2002","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11926-008-0072-z","article-title":"Vasculitis induced by tumor necrosis factor-targeted therapies","volume":"10","author":"Ramos-Casals","year":"2008","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.11.002_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MD.0b013e318190f170","article-title":"A systematic review of the off-label use of biological therapies in systemic autoimmune diseases","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.11.002_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/rheumatology\/kep015","article-title":"A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus","volume":"48","author":"Kishi","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.11.002_bib11","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.lpm.2008.12.031","article-title":"Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab","volume":"38","author":"Nouijai","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.semarthrit.2010.11.002_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-009-0931-6","article-title":"Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment","author":"Taki","year":"2009","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.11.002_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1579-2129(08)60067-1","article-title":"Etanercept as a possible trigger of fatal pulmonary fibrosis","volume":"44","author":"D\u00edez Pi\u00f1a","year":"2008","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib14","first-page":"1222","article-title":"Cutaneous granulomas during infliximab therapy for spondyloarthropathy","volume":"35","author":"Dubosc","year":"2008","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-2007-1016443","article-title":"Drug-induced alveolitis associated with infliximab\/azathioprine therapy","volume":"62","author":"El-Hag","year":"2008","journal-title":"Pneumologie"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000104866","article-title":"Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature","volume":"76","author":"Heresi","year":"2008","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jbspin.2007.10.009","article-title":"Organizing pneumonia after rituximab therapy: two cases","volume":"75","author":"Soubrier","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.11.002_bib18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MEG.0b013e32830fb700","article-title":"Infliximab-associated alveolitis after treatment for severe left-sided ulcerative colitis","volume":"21","author":"Veerappan","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"17","key":"10.1016\/j.semarthrit.2010.11.002_bib19","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMcpc0806979","article-title":"Case records of the Massachusetts General Hospital","volume":"359","author":"Wiener","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.11.002_bib20","first-page":"1151","article-title":"Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis","volume":"34","author":"Hagiwara","year":"2007","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.11.002_bib21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/rheumatology\/kel220","article-title":"Adalimumab-associated pulmonary fibrosis","volume":"45","author":"Huggett","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.11.002_bib22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/rheumatology\/kel090","article-title":"Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment","volume":"45","author":"Lindsay","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10165-006-0491-5","article-title":"Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody","volume":"16","author":"Mori","year":"2006","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.11.002_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jbspin.2007.04.028","article-title":"Exacerbation of interstitial lung disease during etanercept therapy: two cases","volume":"75","author":"Tournadre","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2005.044453","article-title":"Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.11.002_bib26","first-page":"1917","article-title":"Infliximab-associated pneumonitis in rheumatoid arthritis","volume":"33","author":"Hennum","year":"2006","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.11.002_bib27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3346\/jkms.2006.21.5.946","article-title":"Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis","volume":"21","author":"Kang","year":"2006","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib28","first-page":"622","article-title":"Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis","volume":"33","author":"Ost\u00f6r","year":"2006","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.11.002_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejim.2006.02.010","article-title":"Infliximab-induced non-specific interstitial pneumonia and lupus-like eruption","volume":"17","author":"Pataka","year":"2006","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.11.002_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.smj.0000223696.21984.1f","article-title":"Enbrel-induced interstitial lung disease","volume":"99","author":"Quintos-Macasa","year":"2006","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.11.002_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.21716","article-title":"Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab","volume":"55","author":"Schoe","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib32","first-page":"1189","article-title":"Interstitial pneumonitis associated with infliximab therapy","volume":"33","author":"Villeneuve","year":"2006","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.11.002_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.MIB.0000219811.54115.aa","article-title":"Interstitial pneumonitis after infliximab therapy for Crohn's disease","volume":"12","author":"Weatherhead","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"49","key":"10.1016\/j.semarthrit.2010.11.002_bib34","first-page":"3788","article-title":"TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis","volume":"102","author":"Tengstrand","year":"2005","journal-title":"Lakartidningen"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.11.002_bib35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.3800333","article-title":"Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy","volume":"8","author":"Yousem","year":"2005","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/03009740410005836","article-title":"Severe interstitial pneumonitis associated with infliximab therapy","volume":"33","author":"Chatterjee","year":"2004","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.11.002_bib37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4065\/79.7.949","article-title":"Rituximab-induced acute pulmonary fibrosis","volume":"79","author":"Leon","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1579-2129(06)60237-1","article-title":"Pulmonary infiltrates after initiation of treatment with infliximab for adult Still's disease","volume":"41","author":"Mart\u00edn Carrasco","year":"2005","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00054725-200405000-00016","article-title":"Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease","volume":"10","author":"Panagi","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.11.002_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajh.20135","article-title":"Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP)","volume":"77","author":"Swords","year":"2004","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.11187","article-title":"Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis","volume":"49","author":"Courtney","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.10803","article-title":"Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis","volume":"47","author":"Kramer","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.11.002_bib43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.11188","article-title":"Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis","volume":"49","author":"Kramer","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.11.002_bib44","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.11.002_bib45","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3899\/jrheum.080791","article-title":"Postmarketing surveillance of the safety and effectiveness of etanercept in Japan","volume":"36","author":"Koike","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.11.002_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.2007.072967","article-title":"Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis","volume":"67","author":"Takeuchi","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/03009740601153774","article-title":"Rheumatoid arthritis treatment and the risk of severe interstitial lung disease","volume":"36","author":"Wolfe","year":"2007","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib48","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1186\/ar1715","article-title":"Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey","volume":"7","author":"De Bandt","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.11.002_bib49","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib50","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"BSRBR Control Centre Consortium, Symmons DP; British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1183\/09031936.94.07030515","article-title":"Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice","volume":"7","author":"Piguet","year":"1994","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.11.002_bib52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1172\/JCI118029","article-title":"Expression of a tumour necrosis factor-\u03b1 transgene in murine lung causes lymphocytic and fibrosing alveolitis: a mouse model of progressive pulmonary fibrosis","volume":"96","author":"Miyazaki","year":"1995","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib53","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/01.TP.0000074700.30536.76","article-title":"Tumor necrosis factor-a in a porcine bronchial model of obliterative bronchiolitis","volume":"76","author":"Alho","year":"2003","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.11.002_bib54","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.170.1.567","article-title":"Repression of bleomycin-induced pneumopathy by TNF","volume":"170","author":"Kuroki","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/ajrccm\/138.3.652","article-title":"Tumor necrosis factor interacts with interleukin-1 and interferon to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and independent mechanisms","volume":"38","author":"Elias","year":"1988","journal-title":"Am Rev Respir Dis"},{"issue":"8B","key":"10.1016\/j.semarthrit.2010.11.002_bib56","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1582-4934.2008.00647.x","article-title":"TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation","volume":"13","author":"Sullivan","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib57","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1165\/rcmb.2007-0276OC","article-title":"P21 regulates TGF-beta1-induced pulmonary responses via a TNF-alpha-signaling pathway","volume":"38","author":"Yamasaki","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.11.002_bib58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"26","key":"10.1016\/j.semarthrit.2010.11.002_bib59","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1056\/NEJM200306263482619","article-title":"Interstitial pneumonitis related to rituximab therapy","volume":"348","author":"Burton","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.11.002_bib60","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1080\/10428190410001697359","article-title":"Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma","volume":"45","author":"Alexandrescu","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.11.002_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1532\/IJH97.04163","article-title":"A case of interstitial pneumonia induced by rituximab therapy","volume":"81","author":"Hiraga","year":"2005","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.11.002_bib62","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1080\/10428190500144615","article-title":"Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim","volume":"46","author":"Macartney","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.11.002_bib63","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ajh.20910","article-title":"Rituximab-induced interstitial lung disease","volume":"82","author":"Wagner","year":"2007","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.11.002_bib64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3349\/ymj.2008.49.1.155","article-title":"Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma","volume":"49","author":"Kim","year":"2008","journal-title":"Yonsei Med J"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.11.002_bib65","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1080\/10428190802270886","article-title":"Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma","volume":"49","author":"Liu","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.11.002_bib66","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.thj.6200133","article-title":"Tumor necrosis factor \u03b1 release is a major biological event associated with rituximab treatment","volume":"2","author":"Bienvenu","year":"2001","journal-title":"Hematol J"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib67","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1183\/09031936.00080209","article-title":"Rituximab-induced lung disease: a systematic literature review","volume":"35","author":"Liot\u00e9","year":"2010","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.11.002_bib68","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1148\/rg.285075223","article-title":"Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation","volume":"28","author":"Attili","year":"2008","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.11.002_bib69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.2004.025676","article-title":"Primary Sj\u00f6gren's syndrome: new clinical and therapeutic concepts","volume":"64","author":"Ramos-Casals","year":"2005","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017210002519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017210002519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T04:35:06Z","timestamp":1559968506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017210002519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0049017210002519"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2010.11.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13984968.15436074","asserted-by":"object"}]},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}